T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for STP938 in adults with relapsed or refractory B-cell and T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma [Phase 2]
Phase 2 study of ruxolitinib in relapsed or refractory T- or NK-cell lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating GW5282 in combination with Golidocitinib (BEI-DOU3) for T-cell lymphoma; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating mogamulizumab in combination with DA-EPOCH or CHOEP for aggressive T-cell lymphoma and is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Enasidenib in People With T-Cell Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating enasidenib in people with T-cell lymphoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) [Phase 1, Phase 2]
This trial investigates BI-1808 as a single agent and in combination with pembrolizumab (Keytruda) for advanced malignancies, including ovar…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma [Phase 1]
This entry notes a Phase 1 clinical trial evaluating ONO-4685 in patients with relapsed or refractory T-cell lymphoma that is currently recr…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD4CAR for CD4+ Leukemia and Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CD4CAR as a CAR-T therapy for T-cell lymphoma and T-cell leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Novel Therapeutic Approach for Human T-cell Malignancies
A clinical trial update indicates a novel therapeutic approach is being investigated for adult T-cell leukemia/lymphoma and is currently rec…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma [Phase 1]
Treeline Biosciences is conducting a Phase 1 study of TLN-254 in participants with relapsed or refractory T-cell lymphoma, currently recruit…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: MB-105 in Patients With CD5 Positive T-cell Lymphoma [Phase 2]
This update reports a Phase 2 clinical trial of MB-105 for CD5-positive T-cell lymphoma, which is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating CD7 CAR-T therapy in combination with autologous hematopoietic stem cell transplantation for CD7-posi…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
This Phase 2 clinical trial is evaluating PI3K inhibitors for relapsed/refractory indolent T/NK-cell lymphomas and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of autologous stem cell transplantation combined with CD7-CART therapy for CD7-pos…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia [NA]
A clinical trial evaluating a CD7-targeted CAR-T cell therapy for relapsed/refractory CD7-positive T-cell lymphoma and CD7-positive acute ly…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for Tulmimetostat DZR123 (CPI-0209) in adults with advanced solid tumors and various lymphomas. The study is in Phase …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies [Phase 1]
A Phase 1 clinical trial (NCT06699771) is evaluating the safety, tolerability, and preliminary efficacy of GCC2005. The trial focuses on pat…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 trials are evaluating CAR-T cell therapy for relapsed or refractory malignant hematologic tumors, including aggressi…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies [Phase 1]
Phase 1 clinical trial evaluating a CD5-targeted CAR-NK cell therapy for relapsed/refractory T-cell hematologic malignancies (T-ALL and T-ce…